rs1131692148
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_181507.2(HPS5):c.1417C>T(p.Gln473*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q473Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_181507.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Hermansky-Pudlak syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
- Hermansky-Pudlak syndrome without pulmonary fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HPS5 | ENST00000349215.8 | c.1417C>T | p.Gln473* | stop_gained | Exon 12 of 23 | 1 | NM_181507.2 | ENSP00000265967.5 | ||
| HPS5 | ENST00000396253.7 | c.1075C>T | p.Gln359* | stop_gained | Exon 11 of 22 | 1 | ENSP00000379552.3 | |||
| HPS5 | ENST00000438420.6 | c.1075C>T | p.Gln359* | stop_gained | Exon 11 of 22 | 1 | ENSP00000399590.2 | |||
| HPS5 | ENST00000531848.1 | c.1075C>T | p.Gln359* | stop_gained | Exon 11 of 11 | 5 | ENSP00000431758.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hermansky-Pudlak syndrome 5 Pathogenic:2
- -
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at